Today, we’re diving into the science behind tobacco-free “modern” oral nicotine pouches—products that have rapidly gained popularity as an alternative to traditional smoking and smokeless tobacco. These pouches, which deliver nicotine through a cellulose-based matrix without containing any tobacco leaf, are often marketed as a less harmful option for nicotine users.
In this episode, we’ll explore the findings of a comprehensive study that compared the chemical profiles and toxicant levels of nicotine pouches with those of Swedish snus and nicotine replacement therapies (NRTs) like gum and lozenges. The research analyzed a broad spectrum of harmful and potentially harmful constituents, revealing that nicotine pouches contain significantly lower levels of toxicants than snus and are on par with NRTs for most compounds. In fact, for the majority of toxicants measured, levels in nicotine pouches were either undetectable or comparable to those found in medicinal nicotine products, and far below those in traditional tobacco products.
We’ll discuss what these results mean for harm reduction, where nicotine pouches fit on the continuum of risk among nicotine products, and what further research is needed to fully understand their long-term health impacts. Whether you’re a public health professional, a nicotine user, or just curious about emerging trends in tobacco harm reduction, this episode will give you a clear, evidence-based overview of where these new products stand in the evolving landscape of nicotine delivery.
